Coronary disease & ACS

Coronary angiography-derived index of microcirculatory resistance and evolution of infarct pathology after ST-segment-elevation myocardial infarction

Eur Heart J Cardiovasc ImagingPublished Prospective cohort study

Main finding · Final infarct size >25%Result — go to the resultAdjusted odds ratio 3.00 95% CI 1.23–7.32

Authors' conclusion

Angio-IMR immediately post-PPCI showed a significant association with the extent and evolution of infarct pathology. An angio-IMR >40 U indicated extensive microvascular damage with less regression of infarct size and more persistent iron at follow-up.

Study context

Population
STEMI patients undergoing primary percutaneous coronary intervention (PPCI) with angio-IMR and baseline cardiac magnetic resonance (CMR), enrolled October 2019–August 2021mean age 57.8 years, 84.3% men
Participants
286 patients
Exposure
Angio-IMR >40 U vs angio-IMR ≤40 U after PPCI
  • Angio-IMR >40 Un = 84
Outcome
Evolution of infarct pathology on CMR
Follow-up
3-month follow-up
Methodological detailsCMR at median 3.6 days and 3 months
  • CMR at median 3.6 days and 3 months

Main finding

Final infarct size >25%

Adjusted odds ratio

3.00

95% CI 1.23–7.32

P = 0.016

Angio-IMR >40 U vs Angio-IMR ≤40 U
adjusted OR 3.00 (95% CI 1.23–7.32); P = 0.016

As reported in the abstract

Observational data: associations, not effects.

Further findings

OutcomeAdjusted OR (95% CI)P value
Myocardial iron at follow-upAngio-IMR >40 U vs Angio-IMR ≤40 U · presence5.52 (1.65–18.51)P = 0.006
OutcomeBeta coefficient (95% CI)P value
Myocardial iron at follow-upAngio-IMR >40 U vs Angio-IMR ≤40 U · extent0.27 (0.01–0.53)P = 0.041

MVO

Higher prevalence and extent of MVO with angio-IMR >40 U

Original publication

Coronary angiography-derived index of microcirculatory resistance and evolution of infarct pathology after ST-segment-elevation myocardial infarction. Eur Heart J Cardiovasc Imaging. Published 15 June 2023. doi:10.1093/ehjci/jead141

Summarised from the published abstract; every number is checked against it

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.